FindTrial
Sign In

SPECT/CT Imaging

DEVICE5 trials

Sponsors

University of Michigan, Yale University, Navidea Biopharmaceuticals, NexEos Diagnostics, Inc., Radiomedix, Inc.

Conditions

Colorectal CarcinomaDiabetes MellitusEosinophilic EsophagitisGlioblastoma Multiforme (GBM)Liver MetastasesNon-Hodgkin's LymphomaPancreatic Ductal Adenocarcinoma (PDAC)Peripheral Arterial Disease

Phase 1

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
TerminatedNCT03029988
Navidea BiopharmaceuticalsColorectal Carcinoma, Liver Metastases
Start: 2017-07-26End: 2018-09-24Updated: 2020-09-10
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingNCT07733674
Radiomedix, Inc.Glioblastoma Multiforme (GBM), Pancreatic Ductal Adenocarcinoma (PDAC)
Start: 2026-08-15End: 2027-06-30Target: 20Updated: 2026-08-07

Phase 2

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis
CompletedNCT05757856
NexEos Diagnostics, Inc.Eosinophilic Esophagitis
Start: 2023-01-20End: 2025-05-22Updated: 2026-05-14

Unknown Phase

Imaging Based Dosimetry for Individualized Internal Emitter Therapy
CompletedNCT01988272
University of MichiganNon-Hodgkin's Lymphoma
Start: 2011-06-30End: 2016-01-31Updated: 2016-05-18
SPECT/CT Imaging of Skeletal Muscle Perfusion
CompletedNCT02791204
Yale UniversityDiabetes Mellitus, Peripheral Arterial Disease
Start: 2016-05-01End: 2026-01-30Updated: 2026-02-24